Home

Μετασχηματιστής Εξειδίκευση Στενό kappa opioid receptor activates p38 Έμεινα έκπληκτος μπαλέτο Κουνώντας

Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the  Brain
Frontiers | Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

Agonist-induced phosphorylation bar code and differential post-activation  signaling of the delta opioid receptor revealed by phosphosite-specific  antibodies | Scientific Reports
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies | Scientific Reports

Dopaminergic Cellular and Circuit Contributions to Kappa Opioid Receptor  Mediated Aversion
Dopaminergic Cellular and Circuit Contributions to Kappa Opioid Receptor Mediated Aversion

Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor  Pharmacology | SpringerLink
Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology | SpringerLink

Constitutive activation of kappa opioid receptors at ventral tegmental area  inhibitory synapses following acute stress | eLife
Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress | eLife

Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior
Molecular Mechanisms of Opioid Receptor-dependent Signaling and Behavior

Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA  Dopamine Neurons | Journal of Neuroscience
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons | Journal of Neuroscience

Dopaminergic cellular and circuit contributions to kappa opioid receptor  mediated aversion
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion

Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands:  Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience

Biased agonists of the kappa opioid receptor suppress pain and itch without  causing sedation or dysphoria | Science Signaling
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling

Kappa Receptors – Opioid Peptides
Kappa Receptors – Opioid Peptides

Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical  Role of the Dynorphin/Kappa Opioid Receptor System
Frontiers | Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System

Kappa opioid receptor signaling in the brain: Circuitry and implications  for treatment | Semantic Scholar
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment | Semantic Scholar

Chronic Kappa opioid receptor activation modulates NR2B: Implication in  treatment resistant depression – topic of research paper in Clinical  medicine. Download scholarly article PDF and read for free on CyberLeninka  open science
Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science

κ-opioid receptor - Wikipedia
κ-opioid receptor - Wikipedia

Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor  activation through phosphorylated c-Jun N-terminal kinase and inhibited by  p38 mitogen-activated protein kinase (MAPK) activation - ScienceDirect
Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation - ScienceDirect

Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal  of Neuroscience
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience

Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and  Revealing New Indications | Pharmacological Reviews
Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications | Pharmacological Reviews

Biased ligands at opioid receptors: Current status and future directions |  Science Signaling
Biased ligands at opioid receptors: Current status and future directions | Science Signaling

Mitogen‐activated protein kinase signaling mediates opioid‐induced  presynaptic NMDA receptor activation and analgesic tolerance - Deng - 2019  - Journal of Neurochemistry - Wiley Online Library
Mitogen‐activated protein kinase signaling mediates opioid‐induced presynaptic NMDA receptor activation and analgesic tolerance - Deng - 2019 - Journal of Neurochemistry - Wiley Online Library

Kappa opioid receptor (KOR) activation study. A): G protein activation... |  Download Scientific Diagram
Kappa opioid receptor (KOR) activation study. A): G protein activation... | Download Scientific Diagram

IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed  the Distinct Binding Interactions of Agonists, Partial Agonists, and  Antagonists with the µ Opioid Receptor
IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor

IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced  Abnormal Behaviors?
IJMS | Free Full-Text | Is p38 MAPK Associated to Drugs of Abuse-Induced Abnormal Behaviors?

Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects
Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects

Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and  Arrestin-dependent in Neurons and Astrocytes* - Journal of Biological  Chemistry
Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes* - Journal of Biological Chemistry

Opioids in cancer: The κ‑opioid receptor (Review)
Opioids in cancer: The κ‑opioid receptor (Review)